ZYBT

Zhengye Biotechnology
ZYBT

11 hedge funds and large institutions have $265K invested in Zhengye Biotechnology in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

36% less capital invested

Capital invested by funds: $416K → $265K (-$151K)

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$92.5K
2
+$54.7K
3
+$41.9K
4
UBS Group
UBS Group
Switzerland
+$10.6K
5
JP Morgan Chase
JP Morgan Chase
New York
+$1.01K

Top Sellers

1
-$38.3K
2
-$5K
3
-$3.91K
4
Morgan Stanley
Morgan Stanley
New York
-$891
Name Holding Trade Value Shares
Change 		Change in
Stake
WG
1
Winton Group
United Kingdom
$72.8K
XT
2
XTX Topco
Cayman Islands
$68.2K
Invesco
3
Invesco
Georgia
$39.9K
Citadel Advisors
4
Citadel Advisors
Florida
$35.2K
Geode Capital Management
5
Geode Capital Management
Massachusetts
$33.4K
UBS Group
6
UBS Group
Switzerland
$10.5K
TRCT
7
Tower Research Capital (TRC)
New York
$2.54K
Morgan Stanley
8
Morgan Stanley
New York
$1.85K
JP Morgan Chase
9
JP Morgan Chase
New York
$526
CIAM
10
Caitong International Asset Management
Hong Kong
$1
Millennium Management
11
Millennium Management
New York
–
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
–